Advancing Suicide Intervention Strategies for Teens During High Risk Periods
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age11-17
SponsorSeattle Children's Hospital
About this trial
To inform the effective management of adolescent suicide risk by evaluating promising treatments and developing the evidence-base for interventions that are well suited for widespread adoption, sustained quality, and impact.
Eligibility criteria
Qualifiers
Provision of signed and dated informed consent form
Youth, aged 11-17
Endorse suicidal ideation and/or behavior
Admitted to acute care (emergency, inpatient medical or inpatient psychiatric) due to suicidality
Disqualifiers
Presence of psychosis, intellectual disability, autism spectrum disorder, eating disorder with unstable vitals
Limited English proficiency that would interfere with the ability to complete study assessments
Trial design
Treatments tested in this trial
- Safety Planning Intervention+ (SPI+)
- Collaborative Assessment and Management of Suicidality (CAMS)
- Treatment As Usual
Treatment groups
306 Participants
are divided into 3 treatment groupsSponsors and collaborators
Seattle Children's Hospital
Lead sponsor
Nationwide Children's Hospital
Collaborator
Source ClinicalTrials.gov